Brief: JHBP CY Says Obtained Investigational New Drug Approval From National Medical Products Administration
06/06/2022 15:24
June 6 (Reuters) - Genor Biopharma Holdings Ltd 6998.HK :
* OBTAINED INVESTIGATIONAL NEW DRUG APPROVAL FROM NATIONAL
MEDICAL
PRODUCTS ADMINISTRATION FOR PHASE I/II CLINICAL TRIALS OF GB263T
Source text for Eikon: ID:nHKS3qhrxB
Further company coverage: 6998.HK
Recent news on Edding Genor group
See all newsBrief: Edding Genor Says CEO Initiates Plan To Purchase Additional Shares In Open Market
Brief: Edding Genor Posts Net Profit Increased To Rmb399.3 Million In 2025
Brief: Genor Biopharma Says NMPA Granted New Drug Application Approval For Lerociclib (Gb491)
Brief: Genor Biopharma, Its Unit & Edding Group Entered Into Merger Agreement
Brief: Genor Biopharma Says Guo Feng Tendered His Resignation As Chairman